Completed PHASE3 INTERVENTIONAL 2-arm NCT03232320

Meditoxin® Treatment in Patients With Cervical Dystonia

A Prospective, Randomized, Multi-center, Phase III, Double-blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of MEDITOXIN in Treatment of Cervical Dystonia

Sponsor: Medy-Tox

Conditions Dystonia Dystonic Disorder

Interventions Meditoxin Placebo

Updated 7 times since 2017 Last updated: Mar 25, 2019 Started: Jul 6, 2017 Primary completion: Oct 31, 2018 Completion: Nov 5, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Dystonia and Dystonic Disorder and is currently completed. Medy-Tox leads this study, which shows 7 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Apr 2019 — Jan 2021 [monthly]

Completed PHASE3

Status: Recruiting → Completed

▶ Show 2 earlier versions

Jun 2018 — Apr 2019 [monthly]

Recruiting PHASE3
Aug 2017 — Jun 2018 [monthly]

Recruiting PHASE3

First recorded

Jul 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medy-Tox

Data source: Medy-Tox

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea